Explore more publications!
Healthcare Times Denmark
Got News to Share?

Press Releases

New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
Aug. 30, 2025

New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups

Indeterminate GlobeNewswire, Inc.
Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034
Sep. 1, 2025

Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034

Indeterminate GlobeNewswire, Inc.
Parathyroid Disease Treatment Market Size, Share & Trends Analysis Report By Product
Aug. 22, 2025

Parathyroid Disease Treatment Market Size, Share & Trends Analysis Report By Product

Neutral EIN Presswire
Nutraceutical Ingredients Market Size to Reach USD 191.45 Billion by 2034, Driven by Functional Foods and Wellness Trends
Aug. 25, 2025

Nutraceutical Ingredients Market Size to Reach USD 191.45 Billion by 2034, Driven by Functional Foods and Wellness Trends

Indeterminate GlobeNewswire, Inc.
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Aug. 20, 2025

Zealand Pharma major shareholder announcement: Van Herk Investments B.V.

Indeterminate GlobeNewswire, Inc.
Non-GMO Food Market Set to Exceed USD 375.42 Billion by 2034 Driven by Health Trends and Consumer Demand
Aug. 29, 2025

Non-GMO Food Market Set to Exceed USD 375.42 Billion by 2034 Driven by Health Trends and Consumer Demand

Indeterminate GlobeNewswire, Inc.
Copenhagen Infrastructure Partners and PensionDanmark launch microgrid specialist company
May. 30, 2025

Copenhagen Infrastructure Partners and PensionDanmark launch microgrid specialist company

Indeterminate GlobeNewswire, Inc.
Zealand Pharma Announces Financial Results for the First Half of 2025
Aug. 14, 2025

Zealand Pharma Announces Financial Results for the First Half of 2025

Indeterminate GlobeNewswire, Inc.
Functional Drinks Market Size Worth USD 439.21 Billion by 2034 with Health and Wellness Trends Driving Growth
Aug. 28, 2025

Functional Drinks Market Size Worth USD 439.21 Billion by 2034 with Health and Wellness Trends Driving Growth

Indeterminate GlobeNewswire, Inc.
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
Aug. 15, 2025

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

Indeterminate GlobeNewswire, Inc.
Personalized Retail Nutrition and Wellness Market to Drive USD 16.25 Billion by 2034
Aug. 13, 2025

Personalized Retail Nutrition and Wellness Market to Drive USD 16.25 Billion by 2034

Indeterminate GlobeNewswire, Inc.
Global Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™
Aug. 15, 2025

Global Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™

Indeterminate GlobeNewswire, Inc.
Food Intolerance Products Market Size Expected to Grow USD 302.26 Billion by 2034, Fueled by Increased Health Awareness
Aug. 22, 2025

Food Intolerance Products Market Size Expected to Grow USD 302.26 Billion by 2034, Fueled by Increased Health Awareness

Indeterminate GlobeNewswire, Inc.
Vitamin Supplements Market Size to Capture USD 113.93 Billion by 2034, Driven by Growing Health Awareness, Innovative Product Forms and AI Integration
Aug. 20, 2025

Vitamin Supplements Market Size to Capture USD 113.93 Billion by 2034, Driven by Growing Health Awareness, Innovative Product Forms and AI Integration

Indeterminate GlobeNewswire, Inc.
Human Blood Products Market to Reach USD 76.36 Billion by 2034, Says Towards Healthcare Research
Aug. 12, 2025

Human Blood Products Market to Reach USD 76.36 Billion by 2034, Says Towards Healthcare Research

Indeterminate GlobeNewswire, Inc.
SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance
Aug. 7, 2025

SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance

Indeterminate GlobeNewswire, Inc.
Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results
Aug. 7, 2025

Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results

Indeterminate GlobeNewswire, Inc.
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
Aug. 7, 2025

Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)

Indeterminate GlobeNewswire, Inc.
IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (Pembrolizumab) for the Treatment of First-line Advanced Melanoma, but Statistical Significance Narrowly Missed
Aug. 11, 2025

IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (Pembrolizumab) for the Treatment of First-line Advanced Melanoma, but Statistical Significance Narrowly Missed

Indeterminate GlobeNewswire, Inc.
Nutritional Supplements Market Size Worth USD 911.65 Billion by 2034 Amid Surging Demand for Personalized Health Solutions
Aug. 8, 2025

Nutritional Supplements Market Size Worth USD 911.65 Billion by 2034 Amid Surging Demand for Personalized Health Solutions

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions